Experts Call for Refinements in Pharmaceutical and Intellectual Property Sectors of U.K.-U.S. Trade Deal

The U.K.-U.S. trade deal represents an essential foundation for the enhancement of economic ties between the two nations. However, experts caution that further refinement is needed, particularly in the areas of pharmaceuticals and intellectual property. According to industry professionals, these sectors require additional focus and negotiation before the trade agreement can be finalized. For more detailed insights, refer to the coverage on Law360.